The Memorandum of Understanding (MoU) was signed by QU President professor Sheikha Abdulla al-Misnad and XULA clinical professor Dr Sara al-Dahir in the presence of QU College of Pharmacy (CPH) dean Dr Ayman el-Kadi, as well as several QU and faculty and students.
The agreement facilitates the mutual exchange of undergraduate and graduate students between QU and XULA in order to help students gain advanced pharmaceutical practices and prepare them to become future healthcare professionals.
As per the terms of the agreement, CPH students will participate annually in 4-week elective clinical/academic internships in a teaching hospital setting at XULA, under the supervision of academic pharmacy practitioners.
Commenting on the agreement, professor al-Misnad said: "QU is pleased to strengthen its partnerships with XULA in another important initiative that brings together expertise in research, teaching and clinical practice benefiting students and faculty from both institutions.
The success of this programme can be attributed to XULA's and Qatar University's commitment to sustain international partnerships.
Following selection of the novel comparison in response to "Xula" on Emergent Mapping Test 3, 14 of 17 children subsequently selected a different novel form when "Coda" was dictated on Outcome Test 1; thus, they discriminated at minimum the novel stimuli from the recently introduced stimuli.
For example, one could follow the emergent mapping test with "Xula" with a second emergent mapping trial; "Coda" would be dictated with a single undefined comparison available, but different from the one selected when "Xula" was dictated.